US Personalized Medicine Market 2018-2023 Global Prominent Key Players are Siemens Healthcare Diagnostics Inc., GE Healthcare, Pfizer Inc., Sanofi, CardioDx Inc., Asuragen Inc. and Bristol-Myers Squibb and others

An expert on premium research reports, Market Research Future has added a report titled " U.S. Personalized Medicine Market Research Report - Forecast To 2023" to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe.

Market Scenario:

The Personalized Medicine Market is the most recent trend in the multibillion–dollar molecular diagnostics industry. Pharmaceutical and biotechnology companies are increasingly turning to personalized medicine in order to improve the drug development process and also to speed up the approval or sanction of new drugs.

Get Sample Copy @

https://www.marketresearchfuture.com/reports/personalized-medicine-market-2937

According to the industry consensus, personalized medicine will not only form an integral part of typical medicine in the next few years, it is also anticipated to reform the development, testing, marketing and prescription of drugs during the next decade. The big pharmaceutical companies eventually will change their tried and tested epic business model to more–targeted and effective healthcare solutions. U.S personalized medicine market is expected to grow at the CAGR of 7.5% during the forecasted period.

Key players of U.S. Personalized Medicine Market:

Laboratory Corporation of America
Quest Diagnostics
Abbott
Becton Dickinson & Co.
Siemens Healthcare Diagnostics Inc.
GE Healthcare
Pfizer Inc.
Sanofi
CardioDx Inc.
Asuragen Inc.
Bristol-Myers Squibb
Segments:

The U.S. Personalized Medicine Market is segmented on the basis of product, application and end users. Based on the product, the market has been segmented as diagnostic, therapeutics, medical care and nutrition and wellness and others. Based on application, the market has been segmented into diagnosis and intervention, drug development and usage, cancer genomics and others. Further on the basis of end users the market has been segmented as hospitals, molecular diagnostic laboratories and testing centers, academic institutes, bio and health informatics companies and others.

Regional Analysis

U.S. accounts for the maximum market share of the personalized medicine market and the market is expected to increase continuously in coming years. This can be attributed to increasing pool of cancer patients along with high healthcare per capita expenditure. Advancing technologies within the liquid biopsy or cancer market is also driving the market and will see strategic growth over the next five years. The two segments of the liquid biopsy market are tumor cell enrichment products and tumor cell detection technologies which are expected to command the maximum market share.

Browse Complete 110 Pages Premium Research Report Enabled with 77 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/personalized-medicine-market-2937

Detailed Table of Contents:

Table Of Contents

1 Introduction

1.1 Definition

1.2 Scope Of Study

1.2.1 Research Objective

1.2.2 Assumptions & Limitations

1.2.2.1 Assumptions

1.2.2.2 Limitations

1.3 Market Structure:

2 Research Methodology

2.1 Research Process:

2.2 Primary Research

2.3 Secondary Research:

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Macroeconomic Indicators

List Of Tables and Figures

List Of Tables

Table 1 U.S. Personalised Medicine Market, By Product, 2017-2023 (Usd Million)

Table 2 U.S. Personalised Medicine Market, By Application, 2017-2023 (Usd Million)

Table 3 U.S. Personalised Medicine Marketby End Users 2017-2023 (Usd Million)

Table 4 U.S. Personalised Medicine Market, By Region 2017-2023 (Usd Million)

List Of Figures

Figure 1 Research Process

Figure 2 Porters Five Forces Model

Figure 3 U.S. Personalised Medicine Market, By Product

Figure 4 U.S. Personalised Medicine Market, By Application

Figure 5 U.S. Personalised Medicine Market, By End Users

Figure 6 U.S. Personalised Medicine Market, By Region

Figure 7 U.S. Personalised Medicine Market: Company Share Analysis, 2016 (%)

...Continued

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/2937

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.